ClinicalTrials.gov
public full text
Public Domain
Virological Response Study of the HCV Vaccine IC41
The objective is to investigate the virological (HCV-RNA) responses following biweekly immunization with IC41. Treatment phase 14 weeks, total study duration including follow-up period 38 weeks.
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Safety, Reactogenicity and Immunogenicity of Heat-stable Rotavirus Vaccine (HSRV) in Adults and Infants#898000
- Study Evaluating the Duration of Immunity in Healthy Adult Volunteers Who Completed Study 6108A1-500#160151
- Gradual Withdrawal of Immune System Suppressing Drugs in Patients Receiving a Liver Transplant#850972
- Proteomic Profiling for Influenza Vaccination - FluMist#967210
- An Effectiveness Study of the Sinovac's Adsorbed COVID-19 (Inactivated) Vaccine#887609
Record · ID 863748
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive